List of Contents

Electronic Skin Patches Market Size, Share, and Trends 2024 to 2034

The global electronic skin patches market size is calculated at USD 6.96 billion in 2025 and is forecasted to reach around USD 17.10 billion by 2034, accelerating at a CAGR of 10.50% from 2025 to 2034. The North America market size surpassed USD 2.33 billion in 2024 and is expanding at a CAGR of 10.64% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : February 2025
  • Report Code : 5551
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis 
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis

Chapter 5. COVID-19 Impact on Electronic Skin Patches Market

5.1. COVID-19 Landscape: Electronic Skin Patches Industry Impact
5.2. COVID-19 - Impact Assessment for the Industry
5.3. COVID-19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers

Chapter 8. Global Electronic Skin Patches Market, By Type

8.1. Electronic Skin Patches Market Revenue and Volume, by Type
8.1.1. Iontophoretic Patches
8.1.1.1. Market Revenue and Volume Forecast 
8.1.2. Monitoring & Diagnostic Patches
8.1.2.1. Market Revenue and Volume Forecast 
8.1.3. Therapeutic Electronic Skin Patches
8.1.3.1. Market Revenue and Volume Forecast 
8.1.4. Others
8.1.4.1. Market Revenue and Volume Forecast

Chapter 9. Global Electronic Skin Patches Market, By Application

9.1. Electronic Skin Patches Market Revenue and Volume, by Application
9.1.1. General Patient Monitoring
9.1.1.1. Market Revenue and Volume Forecast 
9.1.2. Diabetes Management
9.1.2.1. Market Revenue and Volume Forecast 
9.1.3. Cardiovascular Monitoring
9.1.3.1. Market Revenue and Volume Forecast 
9.1.4. Wound Care
9.1.4.1. Market Revenue and Volume Forecast 
9.1.5. Others
9.1.5.1. Market Revenue and Volume Forecast

Chapter 10. Global Electronic Skin Patches Market, By Patient

10.1. Electronic Skin Patches Market Revenue and Volume, by Patient
10.1.1. Adult Patch
10.1.1.1. Market Revenue and Volume Forecast 
10.1.2. Pediatric Patch
10.1.2.1. Market Revenue and Volume Forecast

Chapter 11. Global Electronic Skin Patches Market, By Material

11.1. Electronic Skin Patches Market Revenue and Volume, by Material
11.1.1. Polymer Patch
11.1.1.1. Market Revenue and Volume Forecast 
11.1.2. Silicone Patch
11.1.2.1. Market Revenue and Volume Forecast

Chapter 12. Global Electronic Skin Patches Market, By End-Use

12.1. Electronic Skin Patches Market Revenue and Volume, by End-Use
12.1.1. Hospitals & Clinics
12.1.1.1. Market Revenue and Volume Forecast 
12.1.2. Specialty Clinics
12.1.2.1. Market Revenue and Volume Forecast 
12.1.3. Ambulatory Care
12.1.3.1. Market Revenue and Volume Forecast 
12.1.4. Other
12.1.4.1. Market Revenue and Volume Forecast

Chapter 13. Global Electronic Skin Patches Market, Regional Estimates and Trend Forecast

13.1. North America
13.1.1. Market Revenue and Volume Forecast, by Type 
13.1.2. Market Revenue and Volume Forecast, by Application 
13.1.3. Market Revenue and Volume Forecast, by Patient 
13.1.4. Market Revenue and Volume Forecast, by Material 
13.1.5. Market Revenue and Volume Forecast, by End-Use 
13.1.6. U.S.
13.1.6.1. Market Revenue and Volume Forecast, by Type 
13.1.6.2. Market Revenue and Volume Forecast, by Application 
13.1.6.3. Market Revenue and Volume Forecast, by Patient 
13.1.6.4. Market Revenue and Volume Forecast, by Material 
13.1.6.5. Market Revenue and Volume Forecast, by End-Use  
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Volume Forecast, by Type 
13.1.7.2. Market Revenue and Volume Forecast, by Application 
13.1.7.3. Market Revenue and Volume Forecast, by Patient 
13.1.7.4. Market Revenue and Volume Forecast, by Material 
13.1.7.5. Market Revenue and Volume Forecast, by End-Use 
13.2. Europe
13.2.1. Market Revenue and Volume Forecast, by Type 
13.2.2. Market Revenue and Volume Forecast, by Application 
13.2.3. Market Revenue and Volume Forecast, by Patient 
13.2.4. Market Revenue and Volume Forecast, by Material  
13.2.5. Market Revenue and Volume Forecast, by End-Use  
13.2.6. UK
13.2.6.1. Market Revenue and Volume Forecast, by Type 
13.2.6.2. Market Revenue and Volume Forecast, by Application 
13.2.6.3. Market Revenue and Volume Forecast, by Patient 
13.2.7. Market Revenue and Volume Forecast, by Material  
13.2.8. Market Revenue and Volume Forecast, by End-Use  
13.2.9. Germany
13.2.9.1. Market Revenue and Volume Forecast, by Type 
13.2.9.2. Market Revenue and Volume Forecast, by Application 
13.2.9.3. Market Revenue and Volume Forecast, by Patient 
13.2.10. Market Revenue and Volume Forecast, by Material 
13.2.11. Market Revenue and Volume Forecast, by End-Use 
13.2.12. France
13.2.12.1. Market Revenue and Volume Forecast, by Type 
13.2.12.2. Market Revenue and Volume Forecast, by Application 
13.2.12.3. Market Revenue and Volume Forecast, by Patient 
13.2.12.4. Market Revenue and Volume Forecast, by Material 
13.2.13. Market Revenue and Volume Forecast, by End-Use 
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Volume Forecast, by Type 
13.2.14.2. Market Revenue and Volume Forecast, by Application 
13.2.14.3. Market Revenue and Volume Forecast, by Patient 
13.2.14.4. Market Revenue and Volume Forecast, by Material 
13.2.15. Market Revenue and Volume Forecast, by End-Use 
13.3. APAC
13.3.1. Market Revenue and Volume Forecast, by Type 
13.3.2. Market Revenue and Volume Forecast, by Application 
13.3.3. Market Revenue and Volume Forecast, by Patient 
13.3.4. Market Revenue and Volume Forecast, by Material 
13.3.5. Market Revenue and Volume Forecast, by End-Use 
13.3.6. India
13.3.6.1. Market Revenue and Volume Forecast, by Type 
13.3.6.2. Market Revenue and Volume Forecast, by Application 
13.3.6.3. Market Revenue and Volume Forecast, by Patient 
13.3.6.4. Market Revenue and Volume Forecast, by Material 
13.3.7. Market Revenue and Volume Forecast, by End-Use 
13.3.8. China
13.3.8.1. Market Revenue and Volume Forecast, by Type 
13.3.8.2. Market Revenue and Volume Forecast, by Application 
13.3.8.3. Market Revenue and Volume Forecast, by Patient 
13.3.8.4. Market Revenue and Volume Forecast, by Material 
13.3.9. Market Revenue and Volume Forecast, by End-Use 
13.3.10. Japan
13.3.10.1. Market Revenue and Volume Forecast, by Type 
13.3.10.2. Market Revenue and Volume Forecast, by Application 
13.3.10.3. Market Revenue and Volume Forecast, by Patient 
13.3.10.4. Market Revenue and Volume Forecast, by Material 
13.3.10.5. Market Revenue and Volume Forecast, by End-Use 
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Volume Forecast, by Type 
13.3.11.2. Market Revenue and Volume Forecast, by Application 
13.3.11.3. Market Revenue and Volume Forecast, by Patient 
13.3.11.4. Market Revenue and Volume Forecast, by Material 
13.3.11.5. Market Revenue and Volume Forecast, by End-Use 
13.4. MEA
13.4.1. Market Revenue and Volume Forecast, by Type 
13.4.2. Market Revenue and Volume Forecast, by Application 
13.4.3. Market Revenue and Volume Forecast, by Patient 
13.4.4. Market Revenue and Volume Forecast, by Material 
13.4.5. Market Revenue and Volume Forecast, by End-Use 
13.4.6. GCC
13.4.6.1. Market Revenue and Volume Forecast, by Type 
13.4.6.2. Market Revenue and Volume Forecast, by Application 
13.4.6.3. Market Revenue and Volume Forecast, by Patient 
13.4.6.4. Market Revenue and Volume Forecast, by Material 
13.4.7. Market Revenue and Volume Forecast, by End-Use 
13.4.8. North Africa
13.4.8.1. Market Revenue and Volume Forecast, by Type 
13.4.8.2. Market Revenue and Volume Forecast, by Application 
13.4.8.3. Market Revenue and Volume Forecast, by Patient 
13.4.8.4. Market Revenue and Volume Forecast, by Material 
13.4.9. Market Revenue and Volume Forecast, by End-Use 
13.4.10. South Africa
13.4.10.1. Market Revenue and Volume Forecast, by Type 
13.4.10.2. Market Revenue and Volume Forecast, by Application 
13.4.10.3. Market Revenue and Volume Forecast, by Patient 
13.4.10.4. Market Revenue and Volume Forecast, by Material 
13.4.10.5. Market Revenue and Volume Forecast, by End-Use 
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Volume Forecast, by Type 
13.4.11.2. Market Revenue and Volume Forecast, by Application 
13.4.11.3. Market Revenue and Volume Forecast, by Patient 
13.4.11.4. Market Revenue and Volume Forecast, by Material 
13.4.11.5. Market Revenue and Volume Forecast, by End-Use 
13.5. Latin America
13.5.1. Market Revenue and Volume Forecast, by Type 
13.5.2. Market Revenue and Volume Forecast, by Application 
13.5.3. Market Revenue and Volume Forecast, by Patient 
13.5.4. Market Revenue and Volume Forecast, by Material 
13.5.5. Market Revenue and Volume Forecast, by End-Use 
13.5.6. Brazil
13.5.6.1. Market Revenue and Volume Forecast, by Type 
13.5.6.2. Market Revenue and Volume Forecast, by Application 
13.5.6.3. Market Revenue and Volume Forecast, by Patient 
13.5.6.4. Market Revenue and Volume Forecast, by Material 
13.5.7. Market Revenue and Volume Forecast, by End-Use 
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Volume Forecast, by Type 
13.5.8.2. Market Revenue and Volume Forecast, by Application 
13.5.8.3. Market Revenue and Volume Forecast, by Patient 
13.5.8.4. Market Revenue and Volume Forecast, by Material 
13.5.8.5. Market Revenue and Volume Forecast, by End-Use

Chapter 14. Company Profiles

14.1. 3M Company
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Abbott
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Biolinq Incorporated
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Boston Scientific Corporation
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Dexcom, Inc.
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Epicore Biosystems
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Feeligreen
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. GENTAG, Inc.
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Insulet Corporation
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Intelesens Ltd.
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions

Chapter 16. Appendix

16.1. About Us
16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global electronic skin patches market size is expected to grow from USD 6.30 billion in 2024 to USD 17.10 billion by 2034.

The electronic skin patches market is anticipated to grow at a CAGR of 10.50% between 2025 and 2034.

The major players operating in the electronic skin patches market are 3M Company, Abbott, Biolinq Incorporated, Boston Scientific Corporation, Dexcom, Inc., Epicore Biosystems, Feeligreen, GENTAG, Inc., Insulet Corporation, Intelesens Ltd., Koninklijike Philips N.V., Linxens Healthcare, Medtronic, Inc., Resonetics, VitalConnect, and Others.

The driving factors of the electronic skin patches market are the electronic skin patch device is proven to be an excellent device for remote monitoring for both inpatient and outpatient due to its reliable and convenient properties.

North America region will lead the global electronic skin patches market during the forecast period 2025 to 2034.

Proceed To Buy

USD 5400
USD 3800
USD 2100
USD 2100
USD 7500
Immediate Delivery Available

Plan your call and get expert insights!

Schedule a Meeting Schedule a Meeting

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

down-arrow-imgGet a Sample

Connect with us now; your solution awaits on the other side!

Contact Us